Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Pharmaceuticals has introduced the generic version of Schering-Plough's Clarinex allergy medication, Desloratadine tablets, 5mg.
Subscribe to our email newsletter
Mylan gained final FDA approval for its abbreviated new drug application for Desloratadine Tablets, 5mg, and is shipping the product immediately.
According to IMS Health, Desloratadine Tablets, 5mg, had US sales of approximately $194.6m for the 12 months ending 31 March2012.
At present, Mylan has 167 abbreviated new drug applications awaiting FDA approval representing $83.8bn in annual sales.
Thirty-seven of the pending ANDAs are potential first-to-file opportunities, representing $25.6bn in annual brand sales, for the 12 months ending 31 December 2011, according to IMS Health.